DP
VYGR icon

Diadema Partners’s Voyager Therapeutics VYGR Stock Holding History

Diadema Partners’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$579K Buy
+150,000
New +$591K 0.1% 104

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diadema Partners's VYGR Position: Q1 2026 in Review

Diadema Partners opened a new position in Voyager Therapeutics (VYGR) in Q1 2026: 423,642 shares worth $1.64M. The stake represents 0.28% of the portfolio and ranks #70 among its holdings.

135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Diadema Partners held 423,642 shares of Voyager Therapeutics worth $1.64M as of Q1 2026.
  • Voyager Therapeutics was a new Diadema Partners position in Q1 2026.
  • Voyager Therapeutics made up 0.28% of Diadema Partners's portfolio in Q1 2026, its #70 holding.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.